{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:27Z","timestamp":1792788207278,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971283"],"award-info":[{"award-number":["81971283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171537"],"award-info":[{"award-number":["82171537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071541"],"award-info":[{"award-number":["82071541"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671363"],"award-info":[{"award-number":["81671363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730037"],"award-info":[{"award-number":["81730037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key-Area Research and Development Program of Guangdong Province","award":["2019B030335001"],"award-info":[{"award-number":["2019B030335001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Phosphodiesterases (PDEs) have been associated with psychiatric disorders in observational studies; however, the causality of associations remains unestablished.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Specifically, cyclic nucleotide PDEs were collected from genome-wide association studies (GWASs), including PDEs obtained by hydrolyzing both cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) (PDE1A, PDE2A, and PDE3A), specific to cGMP (PDE5A, PDE6D, and PDE9A) and cAMP (PDE4D and PDE7A). We performed a bidirectional two-sample Mendelian randomization (MR) analysis to investigate the relationship between PDEs and nine psychiatric disorders. The inverse-variance-weighted (IVW) method, MR-Egger, and weighted median were used to estimate causal effects. The Cochran\u2019s Q test, MR-Egger intercept test, MR Steiger test, leave-one-out analyses, funnel plot, and MR pleiotropy residual sum and outlier (MR-PRESSO) were used for sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The PDEs specific to cAMP were associated with higher-odds psychiatric disorders. For example, PDE4D and schizophrenia (SCZ) (odds ratios (OR)\u2009=\u20091.0531,\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2009=\u20090.0414), as well as major depressive disorder (MDD) (OR\u2009=\u20091.0329,\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2009=\u20090.0011). Similarly, PDE7A was associated with higher odds of attention-deficit\/hyperactivity disorder (ADHD) (OR\u2009=\u20091.0861,\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>IVW<\/jats:sub>\n                      \u2009=\u20090.0038). Exploring specific PDE subtypes and increase intracellular cAMP levels can inform the development of targeted interventions. We also observed PDEs (which hydrolyzes both cAMP and cGMP) was associated with psychiatric disorders [OR of PDE1A was 1.0836 for autism spectrum disorder; OR of PDE2A was 0.8968 for Tourette syndrome (TS) and 0.9449 for SCZ; and OR of PDE3A was 0.9796 for MDD;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05]. Furthermore, psychiatric disorders also had some causal effects on PDEs [obsessive\u2013compulsive disorder on increased PDE6D and decreased PDE2A and PDE4D; anorexia nervosa on decreased PDE9A]. The results of MR were found to be robust using multiple sensitivity analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, potential causal relationships between plasma PDE proteins and psychiatric disorders were established. Exploring other PDE subtypes not included in this study could provide a more comprehensive understanding of the role of PDEs in psychiatric disorders. The development of specific medications targeting PDE subtypes may be a promising therapeutic approach for treating psychiatric disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04368-0","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:03:19Z","timestamp":1692622999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study"],"prefix":"10.1186","volume":"21","author":[{"given":"Miaomiao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"4368_CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","volume":"35","author":"MF Azevedo","year":"2014","unstructured":"Azevedo MF, Faucz FR, Bimpaki E, Horvath A, Levy I, de Alexandre RB, et al. Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev. 2014;35:195\u2013233.","journal-title":"Endocr Rev"},{"key":"4368_CR2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fncel.2014.00376","volume":"8","author":"S Averaimo","year":"2014","unstructured":"Averaimo S, Nicol X. Intermingled cAMP, cGMP and calcium spatiotemporal dynamics in developing neuronal circuits. Front Cell Neurosci. 2014;8:376.","journal-title":"Front Cell Neurosci"},{"key":"4368_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1101\/lm.5.3.231","volume":"5","author":"H Son","year":"1998","unstructured":"Son H, Lu YF, Zhuo M, Arancio O, Kandel ER, Hawkins RD. The specific role of cGMP in hippocampal LTP. Learn Mem. 1998;5:231\u201345.","journal-title":"Learn Mem"},{"key":"4368_CR4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.1179735","volume":"327","author":"M Shelly","year":"2010","unstructured":"Shelly M, Lim BK, Cancedda L, Heilshorn SC, Gao H, Poo MM. Local and long-range reciprocal regulation of cAMP and cGMP in axon\/dendrite formation. Science. 2010;327:547\u201352.","journal-title":"Science"},{"key":"4368_CR5","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1523\/JNEUROSCI.0730-22.2022","volume":"42","author":"KR Bechay","year":"2022","unstructured":"Bechay KR, Abduljawad N, Latifi S, Suzuki K, Iwashita H, Carmichael ST. PDE2A inhibition enhances axonal sprouting, functional connectivity, and recovery after stroke. J Neurosci. 2022;42:8225\u201336.","journal-title":"J Neurosci"},{"key":"4368_CR6","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.1065-19.2023","volume":"43","author":"PJ Urrutia","year":"2023","unstructured":"Urrutia PJ, Gonzalez-Billault C. A role for second messengers in axodendritic neuronal polarity. J Neurosci. 2023;43:2037\u201352.","journal-title":"J Neurosci"},{"key":"4368_CR7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","volume":"58","author":"AT Bender","year":"2006","unstructured":"Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev. 2006;58:488\u2013520.","journal-title":"Pharmacol Rev"},{"key":"4368_CR8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","volume":"59","author":"V Lakics","year":"2010","unstructured":"Lakics V, Karran EH, Boess FG. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology. 2010;59:367\u201374.","journal-title":"Neuropharmacology"},{"key":"4368_CR9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(19)30934-1","volume":"394","author":"F Charlson","year":"2019","unstructured":"Charlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. Lancet. 2019;394:240\u20138.","journal-title":"Lancet"},{"key":"4368_CR10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD Disease","year":"2018","unstructured":"Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789\u2013858.","journal-title":"Lancet"},{"key":"4368_CR11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105078","volume":"160","author":"A Bhat","year":"2020","unstructured":"Bhat A, Ray B, Mahalakshmi AM, Tuladhar S, Nandakumar DN, Srinivasan M, et al. Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders. Pharmacol Res. 2020;160: 105078.","journal-title":"Pharmacol Res"},{"key":"4368_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13229-017-0137-9","volume":"8","author":"Autism Spectrum Disorders Working Group of The Psychiatric Genomics C","year":"2017","unstructured":"Autism Spectrum Disorders Working Group of The Psychiatric Genomics C. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Mol Autism. 2017;8:21.","journal-title":"Mol Autism"},{"key":"4368_CR13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnmol.2019.00022","volume":"12","author":"ME Gurney","year":"2019","unstructured":"Gurney ME. Genetic association of phosphodiesterases with human cognitive performance. Front Mol Neurosci. 2019;12:22.","journal-title":"Front Mol Neurosci"},{"key":"4368_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109592","volume":"70","author":"R Farmer","year":"2020","unstructured":"Farmer R, Burbano SD, Patel NS, Sarmiento A, Smith AJ, Kelly MP. Phosphodiesterases PDE2A and PDE10A both change mRNA expression in the human brain with age, but only PDE2A changes in a region-specific manner with psychiatric disease. Cell Signal. 2020;70: 109592.","journal-title":"Cell Signal"},{"key":"4368_CR15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.schres.2019.11.041","volume":"216","author":"J John","year":"2020","unstructured":"John J, Bhattacharyya U, Yadav N, Kukshal P, Bhatia T, Nimgaonkar VL, et al. Multiple rare inherited variants in a four generation schizophrenia family offer leads for complex mode of disease inheritance. Schizophr Res. 2020;216:288\u201394.","journal-title":"Schizophr Res"},{"key":"4368_CR16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1124\/jpet.119.260869","volume":"371","author":"T Enomoto","year":"2019","unstructured":"Enomoto T, Tatara A, Goda M, Nishizato Y, Nishigori K, Kitamura A, et al. A novel phosphodiesterase 1 inhibitor DSR-141562 exhibits efficacies in animal models for positive, negative, and cognitive symptoms associated with schizophrenia. J Pharmacol Exp Ther. 2019;371:692\u2013702.","journal-title":"J Pharmacol Exp Ther"},{"key":"4368_CR17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1523\/JNEUROSCI.5236-10.2011","volume":"31","author":"YF Li","year":"2011","unstructured":"Li YF, Cheng YF, Huang Y, Conti M, Wilson SP, O\u2019Donnell JM, et al. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J Neurosci. 2011;31:172\u201383.","journal-title":"J Neurosci"},{"key":"4368_CR18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/13543784.2017.1364360","volume":"26","author":"J Prickaerts","year":"2017","unstructured":"Prickaerts J, Heckman PRA, Blokland A. Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer\u2019s disease. Expert Opin Investig Drugs. 2017;26:1033\u201348.","journal-title":"Expert Opin Investig Drugs"},{"key":"4368_CR19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00213-018-5134-y","volume":"238","author":"J Gilleen","year":"2021","unstructured":"Gilleen J, Farah Y, Davison C, Kerins S, Valdearenas L, Uz T, et al. An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients. Psychopharmacology. 2021;238:1279\u201389.","journal-title":"Psychopharmacology"},{"key":"4368_CR20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133\u201363.","journal-title":"Stat Med"},{"key":"4368_CR21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/ije\/dyw127","volume":"45","author":"DA Lawlor","year":"2016","unstructured":"Lawlor DA. Commentary: Two-sample Mendelian randomization: opportunities and challenges. Int J Epidemiol. 2016;45:908\u201315.","journal-title":"Int J Epidemiol"},{"key":"4368_CR22","doi-asserted-by":"crossref","first-page":"14357","DOI":"10.1038\/ncomms14357","volume":"8","author":"K Suhre","year":"2017","unstructured":"Suhre K, Arnold M, Bhagwat AM, Cotton RJ, Engelke R, Raffler J, et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun. 2017;8:14357.","journal-title":"Nat Commun"},{"key":"4368_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73\u20139.","journal-title":"Nature"},{"key":"4368_CR24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"key":"4368_CR25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.biopsych.2017.11.026","volume":"83","author":"J Martin","year":"2018","unstructured":"Martin J, Walters RK, Demontis D, Mattheisen M, Lee SH, Robinson E, et al. A genetic investigation of sex bias in the prevalence of attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2018;83:1044\u201353.","journal-title":"Biol Psychiatry"},{"key":"4368_CR26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1176\/appi.ajp.2017.16121402","volume":"174","author":"L Duncan","year":"2017","unstructured":"Duncan L, Yilmaz Z, Gaspar H, Walters R, Goldstein J, Anttila V, et al. Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa. Am J Psychiatry. 2017;174:850\u20138.","journal-title":"Am J Psychiatry"},{"key":"4368_CR27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51:431\u201344.","journal-title":"Nat Genet"},{"key":"4368_CR28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41588-019-0397-8","volume":"51","author":"EA Stahl","year":"2019","unstructured":"Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51:793\u2013803.","journal-title":"Nat Genet"},{"key":"4368_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard DM, Adams MJ, Clarke TK, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343\u201352.","journal-title":"Nat Neurosci"},{"key":"4368_CR30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/mp.2017.154","volume":"23","author":"International Obsessive Compulsive Disorder Foundation Genetics C","year":"2018","unstructured":"International Obsessive Compulsive Disorder Foundation Genetics C, Studies OCDCGA. Revealing the complex genetic architecture of obsessive\u2013compulsive disorder using meta-analysis. Mol Psychiatry. 2018;23:1181\u20138.","journal-title":"Mol Psychiatry"},{"key":"4368_CR31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics C","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"4368_CR32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.2018.18070857","volume":"176","author":"D Yu","year":"2019","unstructured":"Yu D, Sul JH, Tsetsos F, Nawaz MS, Huang AY, Zelaya I, et al. Interrogating the genetic determinants of Tourette\u2019s syndrome and other tic disorders through genome-wide association studies. Am J Psychiatry. 2019;176:217\u201327.","journal-title":"Am J Psychiatry"},{"key":"4368_CR33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","volume":"467","author":"GR Abecasis","year":"2010","unstructured":"Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061\u201373.","journal-title":"Nature"},{"key":"4368_CR34","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35:4851\u20133.","journal-title":"Bioinformatics"},{"key":"4368_CR35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364.","journal-title":"Int J Epidemiol"},{"key":"4368_CR36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.32728","volume":"77","author":"J Xie","year":"2023","unstructured":"Xie J, Huang H, Liu Z, Li Y, Yu C, Xu L, et al. The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive Mendelian randomization study. Hepatology. 2023;77:949\u201364.","journal-title":"Hepatology"},{"key":"4368_CR37","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35:1880\u2013906.","journal-title":"Stat Med"},{"key":"4368_CR38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"4368_CR39","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178:1177\u201384.","journal-title":"Am J Epidemiol"},{"key":"4368_CR40","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34:2926\u201340.","journal-title":"Stat Med"},{"key":"4368_CR41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"4368_CR42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41398-022-02205-4","volume":"12","author":"X Gu","year":"2022","unstructured":"Gu X, Dou M, Cao B, Jiang Z, Chen Y. Peripheral level of CD33 and Alzheimer\u2019s disease: a bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2022;12:427.","journal-title":"Transl Psychiatry"},{"key":"4368_CR43","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89-98.","journal-title":"Hum Mol Genet"},{"key":"4368_CR44","first-page":"587","volume":"27","author":"HT Zhang","year":"2002","unstructured":"Zhang HT, Huang Y, Jin SL, Frith SA, Suvarna N, Conti M, et al. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology. 2002;27:587\u201395.","journal-title":"Neuropsychopharmacology"},{"key":"4368_CR45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2006.09.026","volume":"144","author":"SJ Kanes","year":"2007","unstructured":"Kanes SJ, Tokarczyk J, Siegel SJ, Bilker W, Abel T, Kelly MP. Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity. Neuroscience. 2007;144:239\u201346.","journal-title":"Neuroscience"},{"key":"4368_CR46","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41467-021-21713-3","volume":"12","author":"NS Kim","year":"2021","unstructured":"Kim NS, Wen Z, Liu J, Zhou Y, Guo Z, Xu C, et al. Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation. Nat Commun. 2021;12:1398.","journal-title":"Nat Commun"},{"key":"4368_CR47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","volume":"35","author":"BE Lonze","year":"2002","unstructured":"Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 2002;35:605\u201323.","journal-title":"Neuron"},{"key":"4368_CR48","doi-asserted-by":"crossref","first-page":"11332","DOI":"10.1038\/srep11332","volume":"5","author":"ZZ Wang","year":"2015","unstructured":"Wang ZZ, Yang WX, Zhang Y, Zhao N, Zhang YZ, Liu YQ, et al. Phosphodiesterase-4D knock-down in the prefrontal cortex alleviates chronic unpredictable stress-induced depressive-like behaviors and memory deficits in mice. Sci Rep. 2015;5:11332.","journal-title":"Sci Rep"},{"key":"4368_CR49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2003.08.007","volume":"991","author":"T Itoh","year":"2003","unstructured":"Itoh T, Abe K, Tokumura M, Horiuchi M, Inoue O, Ibii N. Different regulation of adenylyl cyclase and rolipram-sensitive phosphodiesterase activity on the frontal cortex and hippocampus in learned helplessness rats. Brain Res. 2003;991:142\u20139.","journal-title":"Brain Res"},{"key":"4368_CR50","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","volume":"10","author":"MD Houslay","year":"2005","unstructured":"Houslay MD, Schafer P, Zhang KY. Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today. 2005;10:1503\u201319.","journal-title":"Drug Discov Today"},{"key":"4368_CR51","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1126\/science.1112915","volume":"310","author":"JK Millar","year":"2005","unstructured":"Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR, et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science. 2005;310:1187\u201391.","journal-title":"Science"},{"key":"4368_CR52","first-page":"111","volume-title":"Handbook of experimental pharmacology","author":"M Biel","year":"2009","unstructured":"Biel M, Michalakis S. Cyclic nucleotide-gated channels. In: Handbook of experimental pharmacology. Berlin: Springer; 2009. p. 111\u201336."},{"key":"4368_CR53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0968-0004(97)01050-5","volume":"22","author":"MD Houslay","year":"1997","unstructured":"Houslay MD, Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem Sci. 1997;22:217\u201324.","journal-title":"Trends Biochem Sci"},{"key":"4368_CR54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd2058","volume":"5","author":"FS Menniti","year":"2006","unstructured":"Menniti FS, Faraci WS, Schmidt CJ. Phosphodiesterases in the CNS: targets for drug development. Nat Rev Drug Discov. 2006;5:660\u201370.","journal-title":"Nat Rev Drug Discov"},{"key":"4368_CR55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1471-4159.2004.02354.x","volume":"89","author":"T Sasaki","year":"2004","unstructured":"Sasaki T, Kotera J, Omori K. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP\/cyclic AMP-dependent protein kinase\/cyclic AMP-response element binding protein pathway in primary striatal neurons. J Neurochem. 2004;89:474\u201383.","journal-title":"J Neurochem"},{"key":"4368_CR56","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0071-21.2021","author":"Y Huang","year":"2021","unstructured":"Huang Y, Chen Y, Kang Z, Li S. Inhibiting PDE7A enhances the protective effects of neural stem cells on neurodegeneration and memory deficits in sevoflurane-exposed mice. eNeuro. 2021. https:\/\/doi.org\/10.1523\/ENEURO.0071-21.2021.","journal-title":"eNeuro"},{"key":"4368_CR57","volume":"6","author":"JA Morales-Garcia","year":"2011","unstructured":"Morales-Garcia JA, Redondo M, Alonso-Gil S, Gil C, Perez C, Martinez A, et al. Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS ONE. 2011;6: e17240.","journal-title":"PLoS ONE"},{"key":"4368_CR58","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/17460441.2013.787986","volume":"8","author":"M Safavi","year":"2013","unstructured":"Safavi M, Baeeri M, Abdollahi M. New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurological and inflammatory disorders. Expert Opin Drug Discov. 2013;8:733\u201351.","journal-title":"Expert Opin Drug Discov"},{"key":"4368_CR59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.9758\/cpn.2014.12.2.94","volume":"12","author":"MS Seo","year":"2014","unstructured":"Seo MS, Scarr E, Lai CY, Dean B. Potential molecular and cellular mechanism of psychotropic drugs. Clin Psychopharmacol Neurosci. 2014;12:94\u2013110.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"4368_CR60","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/mds.28023","volume":"35","author":"Z Haidar","year":"2020","unstructured":"Haidar Z, Jalkh N, Corbani S, Abou-Ghoch J, Fawaz A, Mehawej C, et al. A homozygous splicing mutation in PDE2A in a family with atypical rett syndrome. Mov Disord. 2020;35:896\u20139.","journal-title":"Mov Disord"},{"key":"4368_CR61","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mds.27286","volume":"33","author":"V Salpietro","year":"2018","unstructured":"Salpietro V, Perez-Duenas B, Nakashima K, San Antonio-Arce V, Manole A, Efthymiou S, et al. A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea. Mov Disord. 2018;33:482\u20138.","journal-title":"Mov Disord"},{"key":"4368_CR62","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/YPG.0000000000000236","volume":"29","author":"X Huang","year":"2019","unstructured":"Huang X, Zhang J, Liu J, Zhang X. Association study of the PDE4D gene and obsessive-compulsive disorder in a Chinese Han population. Psychiatr Genet. 2019;29:226\u201331.","journal-title":"Psychiatr Genet"},{"key":"4368_CR63","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2967\/jnumed.115.166850","volume":"57","author":"M Naganawa","year":"2016","unstructured":"Naganawa M, Waterhouse RN, Nabulsi N, Lin SF, Labaree D, Ropchan J, et al. First-in-human assessment of the novel PDE2A PET radiotracer 18F-PF-05270430. J Nucl Med. 2016;57:1388\u201395.","journal-title":"J Nucl Med"},{"issue":"1","key":"4368_CR64","first-page":"5","volume":"8","author":"R Khalilov","year":"2023","unstructured":"Khalilov R. A comprehensive review of advanced nano-biomaterials in regenerative medicine and drug delivery. Adv Biol Earth Sci. 2023;8(1):5\u201318.","journal-title":"Adv Biol Earth Sci"},{"issue":"1","key":"4368_CR65","first-page":"5","volume":"2","author":"A Hasanzadeh","year":"2017","unstructured":"Hasanzadeh A, et al. Development of doxorubicin-adsorbed magnetic nanoparticles modified with biocompatible copolymers for targeted drug delivery in lung cancer. Adv Biol Earth Sci. 2017;2(1):5\u201321.","journal-title":"Adv Biol Earth Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04368-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04368-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04368-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:33:06Z","timestamp":1700458386000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04368-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4368"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04368-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read the final version and approved it.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"560"}}